SeaStar Medical Holding (ICU) Other Non Operating Income (2022 - 2025)
SeaStar Medical Holding's (ICU) quarterly Other Non Operating Income came in at -$246000.0 in Q2 2025, down 117.13% YoY from $1.4 million in Q2 2024, and down 564.15% on a QoQ basis from $53000.0 in Q1 2025.
SeaStar Medical Holding (ICU) Other Non Operating Income (2022 - 2025) Analysis & Trends
SeaStar Medical Holding (ICU) has 4 years of Other Non Operating Income data on file, last reported at -$246000.0 in Q2 2025.
- Quarterly Other Non Operating Income fell 117.13% year-over-year to -$246000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7.3 million (up 162.65% YoY) and the FY2025 annual result came in at -$3000.0, down 101.52% from the prior year.
- Other Non Operating Income retreated to -$246000.0 in Q2 2025, from $53000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $7.5 million in Q4 2024 to a low of -$8.7 million in Q1 2024.
- A 4-year average of -$457166.7 and a median of -$34500.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income tumbled 3956.56% — and 2024, when it surged 1274.09%.
- Tracing ICU's Other Non Operating Income over 4 years: stood at -$122000.0 in 2022, then soared by 549.18% to $548000.0 in 2023, then surged by 1274.09% to $7.5 million in 2024, then slumped by 103.27% to -$246000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$246000.0 (Q2 2025), $53000.0 (Q1 2025), and $7.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -246,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | 7.53 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | -8.75 Mn |
| Dec 31, 2023 | 548,000.00 |
| Sep 30, 2023 | -4.95 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | -2.52 Mn |
| Sep 30, 2022 | -122,000.00 |
| Jun 30, 2022 | 410,000.00 |
| Mar 31, 2022 | -192,000.00 |